+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity



Oxaliplatin regulates expression of stress ligands in ovarian cancer cells and modulates their susceptibility to natural killer cell-mediated cytotoxicity



International Immunology 27(12): 621-632



Selected cytotoxic chemicals can provoke the immune system to recognize and destroy malignant tumors. Most of the studies on immunogenic cell death are focused on the signals that operate on a series of receptors expressed by dendritic cells to induce tumor antigen-specific T-cell responses. Here, we explored the effects of oxaliplatin, an immunogenic cell death inducer, on the induction of stress ligands and promotion of natural killer (NK) cell-mediated cytotoxicity in human ovarian cancer cells. The results indicated that treatment of tumor cells with oxaliplatin induced the production of type I interferons and chemokines and enhanced the expression of major histocompatibility complex class I-related chains (MIC) A/B, UL16-binding protein (ULBP)-3, CD155 and TNF-related apoptosis-inducing ligand (TRAIL)-R1/R2. Furthermore, oxaliplatin but not cisplatin treatment enhanced susceptibility of ovarian cancer cells to NK cell-mediated cytolysis. In addition, activated NK cells completely abrogated the growth of cancer cells that were pretreated with oxaliplatin. However, cancer cells pretreated with the same concentration of oxaliplatin alone were capable of potentiating regrowth over a period of time. These results suggest an advantage in combining oxaliplatin and NK cell-based therapy in the treatment of ovarian cancer. Further investigation on such potential combination therapy is warranted.

(PDF emailed within 0-6 h: $19.90)

Accession: 058488012

Download citation: RISBibTeXText

PMID: 26138671

DOI: 10.1093/intimm/dxv041


Related references

Interferon gamma up regulates the susceptibility of human neuroblastoma cells to natural killer cell mediated and antibody dependent cellular cytotoxicity. Schmidt, R E (Ed ) Natural Killer Cells: Biology And Clinical Application; 6th International Natural Killer Cell Workshop, Goslar, Germany, July 26-29, 1989 Xii+318p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 216-220, 1990

Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. Journal of Virology 81(18): 9707-9717, 2007

The susceptibility of kaposi sarcoma cells to natural killer nk cell mediated cytotoxicity. FASEB Journal 5(4): A631, 1991

Enhanced sensitivity of colon tumour cells to natural killer cell cytotoxicity after mild thermal stress is regulated through HSF1-mediated expression of MICA. International Journal of Hyperthermia 29(5): 480-490, 2014

Effect of irradiation-induced intercellular adhesion molecule-1 expression on natural killer cell-mediated cytotoxicity toward human cancer cells. CytoTherapy 20(5): 715-727, 2018

E-cadherin expression on human carcinoma cell affects trastuzumab-mediated antibody-dependent cellular cytotoxicity through killer cell lectin-like receptor G1 on natural killer cells. International Journal of Cancer 128(9): 2125-2137, 2011

Decreased susceptibility of squamous cell carcinoma of the head and neck targets pretreated with interferon-gamma to antibody-dependent cell-mediated cytotoxicity mediated by human natural killer cells. Proceedings of the American Association for Cancer Research Annual Meeting 36(0): 469, 1995

Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF). Journal of Immunology 130(6): 2965-2968, 1983

Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis. Immunology 86(2): 263-269, 1995

Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back - Comment on Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis by Rohner et al.. Leukemia Research 32(4): 676-677, 2008

The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands. Bju International 108(9): 1520-1526, 2011

Downregulation of miR-302c and miR-520c by 1,25OH2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity. British Journal of Cancer, 2013

Transforming growth factor-β1 regulates human renal proximal tubular epithelial cell susceptibility to natural killer cells via modulation of the NKG2D ligands. International Journal of Molecular Medicine 36(4): 1180-1188, 2016

c-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis. Blood 123(23): 3585-3595, 2014

FasL expression on pig cells suppresses human natural killer cell mediated-cytotoxicity. Transplantation Proceedings 31(7): 2704-2706, 1999